Ann: Ryoncil Pricing Set and Available This Quarter, page-436

  1. 3,063 Posts.
    lightbulb Created with Sketch. 323
    I get that. I really do. and if there was no other option for raising revenue going into the future - I'd probably agree with you.

    profiteering on sick kids isnt the hill you want to die on. its a very very bad look.

    why not keep marching towards the goal: use the aGVHD treatment to get a foot in the door, as a precedent for future approvals such as CLBP and CHF. and make all the development costs back then? like has always been the plans

    seriously. shareholders have been patient enough thus far. why get greedy now?

    keep doing the aGVHD at cost.

    who in their right mind would disagree?
    Last edited by Pooslice: 28/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.65
Change
0.030(1.85%)
Mkt cap ! $2.108B
Open High Low Value Volume
$1.64 $1.67 $1.63 $4.884M 2.962M

Buyers (Bids)

No. Vol. Price($)
3 10583 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.66 16415 4
View Market Depth
Last trade - 16.12pm 27/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.